Sigilon Competitors, Revenue and Alternatives
Estimated Revenue & Financials
- Sigilon's estimated annual revenue is currently $17.1M per year.
- Sigilon's estimated revenue per employee is $155,000
- Sigilon's total funding is $23.5M.
- Sigilon has 110 Employees.
- Sigilon grew their employee count by 4% last year.
- Sigilon currently has 2 job openings.
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding||Pricing|
|Cell Signaling ...||$89.4M||577||N/A||N/A||N/A|
What Is Sigilon?
Harnessing the full power of cell therapeutics. Cambridge, MAkeywords:N/A
Number of Employees
Employee Growth %
|James Watson||Chief Business Officer And President Islet Cell Therapy|
|Anne Altmeyer||Chief Business Officer||Email Available|
|Derrick Allen||Associate Principal Scientist|
|Vanya Sagar||VP, Head of Human Resources||Email Available|
|Susan Drapeau||VP, Head Device and Delivery Engineering|
|Anthony Garrity||Senior Manager, IT||Email Available|
|Michael Baldwin||Director Of Business Development|
|Marina Mihova||Director Clinical Operations|
|Jelena Garafalo||Senior Director Medical Affairs||Email Available|
|Marianthi Papakosta||Director, Pipeline Development|
“This is the first of what we hope will be multiple Orphan Drug Designations for Sigilon as we continue progressing novel therapies for chronic ...
The Food and Drug Administration (FDA) has granted Orphan Drug designation to SIG-001 (Sigilon Therapeutics) for the treatment of ...
The U.S. Food and Drug Administration (FDA) has granted orphan drug status to Sigilon Therapeutics' candidate cell therapy, called SIG-001, ...
Sigilon Executive Hires
|2018-01-05||David Moller||Chief Scientific Officer||Article|
|2018-11-14||Deya Corzo||Chief Medical Officer||Article|